UFPT:NSD-UFP Technologies Inc (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 358.42

Change

0.00 (0.00)%

Market Cap

USD 2.72B

Volume

0.11M

Analyst Target

USD 50.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-22 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

N/A

USD 28.22B
PODD Insulet Corporation

N/A

USD 16.59B
BRKR Bruker Corporation

N/A

USD 10.23B
MASI Masimo Corporation

N/A

USD 6.49B
TMDX TransMedics Group Inc

N/A

USD 5.04B
PRCT Procept Biorobotics Corp

N/A

USD 4.32B
AXNX Axonics Modulation Technologie..

N/A

USD 3.53B
QDEL Quidel Corporation

N/A

USD 3.05B
TNDM Tandem Diabetes Care Inc

N/A

USD 2.92B
LIVN LivaNova PLC

N/A

USD 2.76B

ETFs Containing UFPT

XHE SPDR® S&P Health Care Eq.. 2.26 % 0.35 %

N/A

USD 0.23B
JSML Janus Henderson Small Cap.. 1.99 % 0.50 %

N/A

USD 0.23B
DWAS Invesco DWA SmallCap Mome.. 1.35 % 0.60 %

N/A

USD 0.99B
BFOR Barron's 400 ETF 0.43 % 0.65 %

N/A

USD 0.15B
JPSE JPMorgan Diversified Retu.. 0.37 % 0.29 %

N/A

USD 0.52B
RZG Invesco S&P SmallCap 600.. 0.00 % 0.35 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 108.34% 93% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 108.34% 93% A 95% A
Trailing 12 Months  
Capital Gain 128.42% 92% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 128.42% 92% A 95% A
Trailing 5 Years  
Capital Gain 830.48% 100% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 830.48% 100% F 98% N/A
Average Annual (5 Year Horizon)  
Capital Gain 52.42% 85% B 91% A-
Dividend Return 52.42% 85% B 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 32.94% 83% B 57% F
Risk Adjusted Return 159.17% 100% F 100% F
Market Capitalization 2.72B 91% A- 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.